Interstitial lung disease due to anti-TNF use in the treatment of psoriasis
Abstract Psoriasis is a chronic inflammatory disease that affects the skin variably, according to genetic and environmental factors. Some patients may benefit from systemic treatment with immunobiological agents, drugs that can be accompanied by several adverse effects. A case of a 58-year-old patient undergoing treatment for psoriasis with adalimumab for five years is reported. Alterations compatible with interstitial pneumonia were detected with important regression after adalimumab discontinuation. This case is relevant due to the scarcity of reports on late pulmonary adverse effect of anti-TNF treatment of psoriasis..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:96 |
|---|---|
| Enthalten in: |
Anais Brasileiros de Dermatologia - 96(2021), 4, Seite 447-450 |
| Sprache: |
Englisch ; Portugiesisch |
|---|
| Beteiligte Personen: |
Débora Dorneles Cunha de Queiroz Turíbio [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1016/j.abd.2020.08.016 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ012109592 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ012109592 | ||
| 003 | DE-627 | ||
| 005 | 20230310042344.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.abd.2020.08.016 |2 doi | |
| 035 | |a (DE-627)DOAJ012109592 | ||
| 035 | |a (DE-599)DOAJbb20fdb13777491c9600a52289f30147 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a por | ||
| 050 | 0 | |a RL1-803 | |
| 100 | 0 | |a Débora Dorneles Cunha de Queiroz Turíbio |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Interstitial lung disease due to anti-TNF use in the treatment of psoriasis |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Psoriasis is a chronic inflammatory disease that affects the skin variably, according to genetic and environmental factors. Some patients may benefit from systemic treatment with immunobiological agents, drugs that can be accompanied by several adverse effects. A case of a 58-year-old patient undergoing treatment for psoriasis with adalimumab for five years is reported. Alterations compatible with interstitial pneumonia were detected with important regression after adalimumab discontinuation. This case is relevant due to the scarcity of reports on late pulmonary adverse effect of anti-TNF treatment of psoriasis. | ||
| 650 | 4 | |a Adalimumab | |
| 650 | 4 | |a Interstitial lung diseases | |
| 650 | 4 | |a Psoriasis | |
| 653 | 0 | |a Dermatology | |
| 700 | 0 | |a Francisco Clitson Sousa Oliveira |e verfasserin |4 aut | |
| 700 | 0 | |a Sandra Maria Fonseca Barreto |e verfasserin |4 aut | |
| 700 | 0 | |a Thaís Barros Felippe Jabour |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Anais Brasileiros de Dermatologia |d Sociedade Brasileira de Dermatologia, 2004 |g 96(2021), 4, Seite 447-450 |w (DE-627)DOAJ000124419 |x 03650596 |7 nnns |
| 773 | 1 | 8 | |g volume:96 |g year:2021 |g number:4 |g pages:447-450 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.abd.2020.08.016 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/bb20fdb13777491c9600a52289f30147 |z kostenfrei |
| 856 | 4 | 0 | |u http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962021000400447&tlng=en |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/0365-0596 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 96 |j 2021 |e 4 |h 447-450 | ||